Spectrum Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Spectrum Pharmaceuticals

22/03/2023 13:31

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 5 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 11 cents per share.
    * Revenue was $10.11 million​; analysts expected $8.92
million. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 5 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had risen by 124.0%
this
quarter.
    * The company reported a quarterly loss of $8.99 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.05          Beat
 Sep. 30 2022      -0.15          -0.12          Beat
 Jun. 30 2022      -0.16          -0.17          Missed
 Mar. 31 2022      -0.19          -0.08          Beat